0000899243-18-000596.txt : 20180105 0000899243-18-000596.hdr.sgml : 20180105 20180105170212 ACCESSION NUMBER: 0000899243-18-000596 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180103 FILED AS OF DATE: 20180105 DATE AS OF CHANGE: 20180105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daniel Thomas O CENTRAL INDEX KEY: 0001538894 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36510 FILM NUMBER: 18514072 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZAFGEN, INC. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 175 PORTLAND STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02114 BUSINESS PHONE: 617-622-4003 MAIL ADDRESS: STREET 1: 175 PORTLAND STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02114 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-03 0 0001374690 ZAFGEN, INC. ZFGN 0001538894 Daniel Thomas O C/O ZAFGEN, INC., 175 PORTLAND STREET, 4TH FLOOR BOSTON MA 02114 1 0 0 0 Common Stock 2018-01-03 4 A 0 8687 5.18 A 19452 D The common stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2018 on quarterly basis in arrears. /s/ Laurie Burlingame (Attorney-In-Fact) 2018-01-05